Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

SP-111Also known as Δ9-THC morpholinylbutyrate

Water-soluble Δ9-THC ester from the 1970s, an animal research tool less potent and slower than THC.

Level of detail

C₂₉H₄₃NO₄

CAS 55602-38-5

Family
Semi-synthetic cannabinoidEster or prodrug
Molar mass
469.67 g/mol

Updated on

In plain terms

SP-111 is a THC made water-soluble, developed in the early 1970s so that it could be studied more easily in animals. Animals recognised it as THC, but it acted more slowly and needed doses 3 to 6 times higher.

Receptors and activity

Target network

  • Binds or modulates

The lower the cited value, the closer the target sits to SP-111: one ring per factor of 100. A target with no measured value stays on the edge.

Cited values

  1. Benzodiazepine site (GABA-A receptor)Binding (function not established)Ki = 3.1 µM · rat25 out of 100

    Sung SC, Jakubovic A 1987, Prog Neuropsychopharmacol Biol Psychiatry (new tab) · [3H]diazepam displacement, rat brain membranes; competitive inhibition (SP-111A)

Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

Pharmacology

SP-111 is the morpholinobutyric ester of Δ9-THC, one of the first water-soluble THC derivatives: the morpholine nitrogen allows soluble salts to form, whereas THC is resinous and insoluble in water. Zitko et al. (1972) described these nitrogen-bearing esters, obtained without loss of biological activity, notably to allow self-administration studies in monkeys. In pigeons, Δ9-THC proved 3 to 6 times more potent than SP-111 and faster acting (Dykstra et al. 1975); in drug discrimination, SP-111 was recognised as Δ9-THC by rats and pigeons, with a slower onset of action (Järbe and McMillan 1980). Segal (1978) studied its effects on neuronal activity in the rat brain. Its conversion to Δ9-THC in the body, often assumed, was not measured in the sources found. It was never developed as a medicine.

Key sources.

History

Source
Absent from cannabis: it is an ester of Δ9-THC whose phenol function carries a 4-(morpholin-4-yl)butanoic acid; the morpholine nitrogen allows water-soluble salts to form (SP-111A form). It remained a research tool of the 1970s and 1980s.

Route of preparation

Chemical process

No plant pathway. It is a semi-synthetic amino ester of Δ9-THC at position 1, described here by chemical class only.

Classification

Family, origin and source verification

Family

Semi-synthetic cannabinoid › Ester or prodrug

Chemistry

C5 side chain · neutral form

Verification

Every fact on this entry was checked against its primary sources on 20 October 2026.

Wikipedia (English)

THC morpholinylbutyrate (new tab)

Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.

References

  1. Zitko BA, Howes JF, Razdan RK et al. Water-soluble derivatives of Δ1-tetrahydrocannabinol. Science 1972;177:442-4 (new tab)PMID 5043146
  2. US Patent 5 847 128, Water soluble derivatives of cannabinoids (historical note: first water-soluble ester of Δ9-THC, the morpholinobutyrate ester, Zitko et al. 1972) (new tab)
  3. Dykstra LA, McMillan DE, Harris LS. Effects of Δ9-THC and a water soluble ester of Δ9-THC on schedule-controlled behavior. Pharmacol Biochem Behav 1975;3:29-32 (new tab)PMID 1129353
  4. Segal M. The effects of SP-111, a water-soluble THC derivative, on neuronal activity in the rat brain. Brain Res 1978;139:263-75 (new tab)PMID 624059
  5. Järbe TU, McMillan DE. Δ9-THC as a discriminative stimulus in rats and pigeons: generalization to THC metabolites and SP-111. Psychopharmacology (Berl) 1980;71:281-9 (new tab)PMID 6256796
  6. Sung SC, Jakubovic A. Interaction of a water-soluble derivative of Δ9-tetrahydrocannabinol with [3H]diazepam and [3H]flunitrazepam binding to rat brain membranes. Prog Neuropsychopharmacol Biol Psychiatry 1987;11:335-40 (new tab)PMID 2819954
  7. ANSM, decision of 6 February 2026 amending the list of substances classified as narcotics and the list of psychotropic substances (tetrahydrocannabinols in annex III) (new tab)
  8. ANSM, decision of 22 May 2024 amending the list of substances classified as narcotics (generic benzo[c]chromene class), supplemented by the decision of 3 June 2024 (new tab)
  9. ANSM, consolidated list of substances classified as narcotics, updated 26/06/2026 (new tab)

Identifiers

Names

Common name
SP-111 (Δ9-THC morpholinylbutyrate)
IUPAC name
[(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-yl] 4-morpholin-4-ylbutanoate
Other names
SP-111 · SP-111A · THC morpholinylbutyrate

Identifiers

Formula
C₂₉H₄₃NO₄
CAS
55602-38-5
PubChem CID
6453212(new tab)
InChIKey
HAQNKTBQOIAWDB-DNQXCXABSA-N
SMILES
CCCCCC1=CC2=C([C@@H]3C=C(CC[C@H]3C(O2)(C)C)C)C(=C1)OC(=O)CCCN4CCOCC4

Machine-readable entry (JSON)

LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.